A list of the Neuroscience Program faculty, with their contact information and a brief description of their research interests, is provided below. More details of faculty research and current laboratory rotation opportunities and projects can be found at the Graduate School faculty directory website.

 

Name	Research	Thesis Advisor	Education	Contact	Location	Research
Srdjan D. Antic, M.D.	Y	Y	Y	antic@uchc.edu 860-679-8468	Main Building E3052	Dendritic integration of synaptic inputs; dopaminergic modulation of dendritic excitability.
Rashmi Bansal, Ph.D.	N	Y	Y	bansal@uchc.edu 860-679-1133	Main Building E4014	Developmental, cellular and molecular biology of oligodendrocytes; growth factor regulation of function and its relationship to neurodegenerative disease, including multiple sclerosis.
Elisa Barbarese, Ph.D.	N	N	Y	barbarese@uchc.edu 860-679-3495	Main Building E5053	Molecular and cellular biology of neural cells with emphasis on RNA trafficking.
Kyle Baumbauer, Ph.D.	Y	Y	Y	kbaumbauer@uchc.edu 860-679-7390	Main Building L4019	Pain, injury and inflammation-induced plasticity; nociceptive signaling.
Leslie R. Bernstein, Ph.D.	Y	Y	Y	les@uchc.edu 860-679-4622	Main Building L3047	Behavioral neuroscience; psychoacoustics, binaural hearing.
John H. Carson, Ph.D.	Y	N	Y	jcarson@uchc.edu 860-679-2130	400 Farmington 1431	Molecular/developmental neurobiology; myelination; intracellular RNA trafficking; computational cell biology.
Stormy J. Chamberlain, Ph.D.	Y	Y	Y	chamberlain@uchc.edu 860-679-8351	400 Farmington 1236	Uses induced pluripotent stem cells (iPSCs) to study the human neurogenetic disorders, Angelman syndrome and 15q duplication syndrome.
Bojun Chen, PhD.	Y	Y	Y	bochen@uchc.edu	L4021
Jonathan M. Covault, M.D., Ph.D.	Y	N	Y	covault@uchc.edu 860-679-7560	Main Building L4091	Genetic correlates of alcohol use disorders; role of neuroactive steroids in the effects of alcohol.
Stephen J. Crocker, Ph.D.	Y	Y	Y	crocker@uchc.edu 860-679-8750	Main Building E4054	Brain injury/repair; neurodegenerative diseases; neuroinflammation; myelin injury; neural stem cell differentiation; signal transduction; glia; matrix metalloproteinases/inhibitors.
Elizabeth A. Eipper, Ph.D.	Y	N	Y	eipper@uchc.edu 860-679-8898	Main Building E4041	Cell biology/biochemistry/physiology of peptide synthesis; storage/secretion in neurons and endocrine cells.
Rosaria Guzzo, PhD	Y	Y	Y	guzzo@uchc.edu860-679-3026	Main BuildingE4032	Epigenetic mechanisms underlying pluripotent stem cell differentiation, musculoskeletal development, and tissue homeostasis.
George A. Kuchel, MD, FRCP, AGSF	Y	Y	Y	kuchel@uchc.edu860-679-6796	ASB 2	Aging; neural regulation of bladder function; resilience and neural plasticity.
Eric S. Levine, Ph.D.	Y	Y	Y	eslevine@uchc.edu 860-679-2145	Main Building E3053	Synaptic plasticity; role of endogenous cannabinoids and nerve growth factors in the hippocampus and cerebral cortex.
Yuanhao “James” Li, Ph.D.				jali@uchc.edu 860-679-3836	Main Building E3014	Development of the central nervous system; cellular and molecular mechanisms underlying formation of the mammalian cerebellum
Leslie M. Loew, Ph.D.	Y	Y	Y	les@uchc.edu 860-679-3568	400 Farmington 1608	Morphological determinants of cell physiology; image-based computational models; spatial variations of cell membrane electrophysiology; new optical methods for probing living cells.
Xin-Ming Ma, Ph.D.	Y	N	Y	ma@uchc.edu 860-679-7957	Main Building E4030	Uses Induced pluripotent stem cell (iPSC)-derived neurons are using to study the mechanisms of the human psychiatric disorders, schizophrenia and cocaine addiction. Synaptogenesis and the plasticity of dendritic spines.
Richard E. Mains, Ph.D.	Y	N	Y	mains@uchc.edu 860-679-8894	Main Building E4056	Neuronal tissue culture; peptides; vesicles; enzymes; drug abuse; development; pituitary.
David Martinelli, PhD.	Y	Y	Y	martinelli@uchc.edu860-679-2271	Main BuildingL4003	Genetics, cell biology, biochemistry, and behavioral neuroscience in synaptic adhesion proteins and their role in neuropsychiatric disease.
Royce Mohan, Ph.D.	Y	Y	Y	mohan@uchc.edu 860-679-2020	Main Building L4023	Developing treatments for conditions and diseases of the eye that involve angiogenesis, fibrosis and gliosis. Developed first pharmacological probe of type III intermediate filaments (IFs), demonstrating the effective targeting of vimentin and glial fibrillary acidic protein by the natural product withaferin A.
Douglas L. Oliver, Ph.D.	Y	Y	Y	doliver@uchc.edu 860-679-2241	Main Building L3042	Circuitry and parallel information processing in the auditory system; neurobiology of hearing, deafness, and tinnitus; role of neuronal cell types and intrinsic membrane properties in information processing; structure and function of CNS sensory systems.
Feliks (Ephraim) Trakhtenberg, Ph.D.	Y	Y	Y	trakhtenberg@uchc.edu 860-679-7819	Main Building L4005	Neuroregeneration: Integrating molecular, genetic, bioinformatic, and translational approaches in studying neuronal development, towards engineering gene therapy and nanotechnology-based therapeutics for regenerating injured nerve/brain tissues and connections.
Zhao-Wen Wang, Ph.D.	Y	Y	Y	zwwang@uchc.edu 860-679-7659	Main Building L4017	Molecular mechanism of neurotransmitter release regulation, and molecular mechanisms of gap junction function, assembly and regulation using C. elegans as a model system.
Erin E. Young, Ph.D.				eyoung@uchc.edu 860-679-2852	400 Farmington 6403	Genetic susceptibility to chronic pain following inflammation and injury with the ultimate goal being the determination of the genetic contributions to chronic pain susceptibility in somatic and visceral pain systems.
Ji Yu, Ph.D.	Y	Y	Y	jyu@uchc.edu 860-679-7680	400 Farmington 1605	Optical imaging technology; regulatory mechanisms in dendritic RNA translation; cytoskeletal dynamics.
Lixia Yue, Ph.D.	Y	Y	Y	lyue@uchc.edu 860-679-3069	Main Building EG024	Calcium signaling mechanism and its physiological/pathological functions in various systems.